Brevan Howard Capital Management’s AtriCure ATRC Stock Holding History

Brevan Howard Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52M	Buy	54,447 +44,947	+473%	+$1.26M	0.01%	857
2026 Q1	$271K	Sell	9,500 -10,478	-52%	-$358K	﹤0.01%	1689
2025 Q4	$790K	Buy	19,978 +6,371	+47%	+$234K	0.01%	879
2025 Q3	$480K	Sell	13,607 -9,922	-42%	-$342K	﹤0.01%	1308
2025 Q2	$771K	Buy	23,529 +15,488	+193%	+$503K	﹤0.01%	1182
2025 Q1	$259K	Sell	8,041 -1,823	-18%	-$67.7K	﹤0.01%	911
2024 Q4	$301K	Sell	9,864 -6,877	-41%	-$221K	﹤0.01%	773
2024 Q3	$469K	Buy	+16,741	New	+$413K	﹤0.01%	698

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Brevan Howard Capital Management's ATRC Position: Q2 2026 in Review

Brevan Howard Capital Management increased its AtriCure (ATRC) stake by 473% in Q2 2026, buying an estimated $1.26M and bringing the position to 54,447 shares worth $1.52M. The position accounts for 0.01% of the portfolio, ranked #857.

Brevan Howard Capital Management first reported a position in ATRC in Q3 2024 and has held it in 8 quarters since. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Brevan Howard Capital Management held 54,447 shares of AtriCure worth $1.52M as of Q2 2026.
Brevan Howard Capital Management bought 44,947 AtriCure shares in Q2 2026, an estimated $1.26M.
AtriCure made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #857 holding.
Brevan Howard Capital Management first reported a position in AtriCure in Q3 2024 and has held it in 8 quarters since.
252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.